Does PEMBROLIZUMAB Cause Metastasis? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Metastasis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.
39
Reports of Metastasis with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
14
Deaths
10
Hospitalizations
How Dangerous Is Metastasis From PEMBROLIZUMAB?
Of the 39 reports, 14 (35.9%) resulted in death, 10 (25.6%) required hospitalization, and 6 (15.4%) were considered life-threatening.
Is Metastasis Listed in the Official Label?
Yes, Metastasis is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Metastasis?
RIBOCICLIB (404)
LETROZOLE (284)
TRASTUZUMAB (273)
CYCLOPHOSPHAMIDE (267)
FULVESTRANT (262)
CAPECITABINE (233)
BEVACIZUMAB (225)
CARBOPLATIN (206)
LEUPROLIDE (201)
PACLITAXEL (198)
Which PEMBROLIZUMAB Alternatives Have Lower Metastasis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G